Robin Jones to Receptor, Platelet-Derived Growth Factor beta
This is a "connection" page, showing publications Robin Jones has written about Receptor, Platelet-Derived Growth Factor beta.
Connection Strength
0.186
-
Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue Sarcoma. Mol Cancer Ther. 2021 01; 20(1):132-141.
Score: 0.186